Tag: NKGen Biotech

Browse exclusive Tags!

NKGen’s SNK01 Shows Promise in Phase 1 Trial for Alzheimer’s Treatment

NKGen's SNK01 shows promise in Phase 1 trial for Alzheimer's treatment, with improved neuroinflammation and cognitive function. A potential breakthrough in addressing a critical gap in therapies.

Popular

Subscribe

spot_imgspot_img